Catalysts for Artery Therapeutics Inc
2 tracked
Feb 15, 2026
grant
ARTERY THERAPEUTICS, INC. โ CS6253 Sequential Subcutaneous Pharmacokinetic Study followed by Phase 2A Pla...
Artery Therapeutics Inc
โ
Sep 10, 2025
grant
ARTERY THERAPEUTICS, INC. โ Manufacturing of ABCA1 agonist small molecule peptide CS6253 to support chron...
Artery Therapeutics Inc
โ